B. Lynne Parshall, Director at IONIS PHARMACEUTICALS INC (IONS), sold 5,000 shares at $82.72 ($414K) on 2026-02-11, disclosed to the SEC on 2026-02-13.
Scheduled sale ($414k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-04-17 | $381K | — | Filing → |
| CYTK | SELL | 2026-03-02 | $306K | — | Filing → |
| CYTK | SELL | 2025-11-19 | $324K | — | Filing → |